Is telehealth allowed to prescribe Wegovy in Illinois?

If you’ve been considering medications like Wegovy, Ozempic, or Mounjaro for weight loss but wondered whether you can access them without visiting a doctor’s office in person, you’re not alone. Millions of Americans are exploring telehealth options for obesity treatment—and the good news is that in most cases, yes, you can legally get these medications through telehealth.

But the rules vary by state, and understanding what’s required in your location can help you navigate the process confidently and safely. This guide breaks down the current federal and state regulations, explains how telehealth prescribing works for GLP-1 weight loss drugs, and answers the most common questions patients have in 2025.

What Are GLP-1 Weight Loss Medications?

GLP-1 (glucagon-like peptide-1) receptor agonists are a class of injectable medications originally developed to treat type 2 diabetes. They work by mimicking a natural hormone that regulates blood sugar and appetite. In recent years, higher doses of these drugs have been FDA-approved specifically for chronic weight management.

The three most commonly prescribed GLP-1 medications for weight loss are:

• Wegovy (semaglutide 2.4 mg) – FDA-approved for obesity in adults with a BMI of 30 or higher, or 27 or higher with weight-related health conditions
• Ozempic (semaglutide 0.5–1 mg) – FDA-approved for type 2 diabetes but frequently prescribed off-label for weight loss
• Mounjaro (tirzepatide) – FDA-approved for diabetes; a higher-dose version called Zepbound was approved for obesity in late 2023

These medications are not controlled substances under federal law, which means they’re not subject to the strict DEA rules that govern stimulants like Adderall or phentermine. This distinction is important because it makes telehealth access significantly easier.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Federal Law: Telehealth Prescribing Is Allowed

Under federal regulations, GLP-1 medications like Wegovy and Ozempic can be prescribed via telehealth without requiring an in-person visit.

Here’s why: The Ryan Haight Online Pharmacy Consumer Protection Act—the federal law that typically requires an in-person medical evaluation before prescribing certain medications—applies only to controlled substances. Since semaglutide and tirzepatide are not scheduled drugs, providers can legally prescribe them after establishing a valid patient-provider relationship through a live video consultation.

During the COVID-19 pandemic, the DEA temporarily waived in-person requirements for controlled medications like ADHD stimulants and buprenorphine. As of December 2025, those flexibilities remain in effect through December 31, 2025, with another extension anticipated. However, this federal waiver doesn’t affect GLP-1 drugs—they’ve been telehealth-eligible all along.

Bottom line: Federal law permits prescribing weight loss medications like Wegovy through telehealth, as long as the provider is licensed in your state and conducts an appropriate medical evaluation.

State-by-State Differences: What You Need to Know

While federal law allows telehealth prescribing of these medications, state laws add an extra layer of requirements—and they vary widely. Some states have no special restrictions, while others mandate an initial in-person exam or ongoing monitoring visits.

Here’s what differs state to state:

1. In-Person Exam Requirements

Most states allow you to start treatment entirely online. However, a handful require an initial in-person physical examination before or shortly after beginning therapy. States with this requirement include:

• Arkansas
• Delaware
• Georgia
• Mississippi
• New Jersey
• North Dakota
• South Carolina
• Texas
• Utah
• Virginia

For example, Virginia requires a comprehensive initial evaluation including a physical exam, lab work, and a documented diet and exercise plan before prescribing any weight-loss medication. New Jersey has similar rules, mandating baseline labs and psychological screening.

If you live in one of these states, you may need to visit a local clinic for your first appointment, then continue with telehealth follow-ups. Some telehealth providers (including Klarity Health) can help coordinate in-person components or connect you with local providers to meet state requirements.

2. Follow-Up Visit Frequency

Several states require regular check-ins during treatment:

• Florida mandates at least one follow-up visit every three months while you’re taking weight-loss medications
• Virginia requires a check-in within 30 days of starting therapy
• Connecticut requires that prescriptions include behavioral counseling and lifestyle modification plans

These rules exist to ensure patient safety and appropriate monitoring for side effects or complications.

3. Provider Licensing and Scope of Practice

All prescribers must be licensed in the state where you’re physically located at the time of your telehealth visit. This means a doctor in California cannot prescribe medication to a patient in Texas unless they also hold a Texas medical license.

Nurse practitioners (NPs) and physician assistants (PAs) can prescribe GLP-1 medications in every state, but their level of independence varies:

• Full practice authority states (34 states plus DC as of 2025): NPs can prescribe without physician oversight. Examples include California, New York, Washington, Arizona, and Utah.
• Collaborative practice states: NPs and PAs must work under a physician collaboration or supervision agreement. This includes Texas, Florida, Pennsylvania, Mississippi, and South Carolina.
• Recent expansions: Georgia passed a law in 2024 allowing NPs and PAs to prescribe Schedule II controlled substances with physician delegation—a significant step toward broader prescribing authority.

If you’re working with an NP or PA through telehealth, rest assured this is completely legal and safe, as long as they’re practicing within their state’s scope of practice rules.

How Telehealth Weight Loss Programs Work

Understanding the process can help set realistic expectations. Here’s what typically happens when you seek GLP-1 medications through a telehealth provider:

Step 1: Medical Intake and Screening

You’ll complete a detailed health questionnaire covering:

• Current weight, height, and BMI
• Medical history (thyroid conditions, pancreatitis, gallbladder issues, etc.)
• Current medications and allergies
• Previous weight loss attempts
• Mental health history

Reputable providers screen carefully to ensure you meet clinical criteria (usually BMI ≥30, or ≥27 with comorbidities like diabetes or high blood pressure) and have no contraindications.

Step 2: Live Video Consultation

A licensed clinician (MD, DO, NP, or PA) will meet with you via video to:

• Review your health history
• Discuss your weight loss goals
• Explain how the medication works, including potential side effects
• Confirm you understand the treatment plan and lifestyle changes required
• Obtain informed consent

This step establishes the patient-provider relationship required by law.

Step 3: Prescription and Pharmacy

If approved, your provider will send an electronic prescription to your preferred pharmacy. In most states, these medications can be filled at any licensed pharmacy that stocks them (availability has improved significantly as of 2025).

You’ll typically start with a lower dose to minimize side effects like nausea, then gradually increase over several weeks.

Step 4: Ongoing Monitoring

Legitimate telehealth programs require regular follow-ups—usually monthly at first, then every 2–3 months once stable. During these check-ins, your provider will:

• Track your weight loss progress
• Assess for side effects
• Adjust your dose if needed
• Review lab work (many providers request periodic metabolic panels)
• Reinforce diet and exercise strategies

This ongoing relationship is essential for safety and effectiveness.

Patient Eligibility: Who Can Get These Medications?

Not everyone is a candidate for GLP-1 therapy. Here’s who typically qualifies:

You may be eligible if:

• You have a BMI of 30 or higher (obesity), OR
• You have a BMI of 27 or higher with at least one weight-related health condition (type 2 diabetes, high blood pressure, high cholesterol, sleep apnea, etc.)
• You’ve tried lifestyle modifications (diet and exercise) without sufficient success
• You’re committed to a comprehensive weight management plan

You’re likely not a candidate if:

• You only need to lose a small amount of weight for cosmetic reasons
• You have a personal or family history of medullary thyroid carcinoma
• You have Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• You’re pregnant, planning pregnancy, or breastfeeding
• You have a history of severe pancreatitis or active gallbladder disease
• You have severe gastrointestinal disorders like gastroparesis

Reputable telehealth providers will be upfront about whether you’re a good fit. If a service guarantees you’ll get a prescription without a thorough evaluation, that’s a red flag.

Red Flags: How to Spot Untrustworthy Telehealth Services

The popularity of weight loss medications has unfortunately attracted some questionable operators. Be cautious of any telehealth service that:

1. Promises a prescription without a real evaluation – Legitimate providers require a detailed health history and live video consultation
2. Offers ‘compounded’ or overseas versions – As of May 2025, the FDA banned most compounded semaglutide due to safety concerns. Stick with FDA-approved brand-name medications
3. Doesn’t schedule follow-ups – Ongoing monitoring is essential and required by most state medical boards
4. Isn’t transparent about provider credentials – You should know your provider’s name, license type, and state of licensure
5. Asks you to waive your rights or lacks clear contact information

What to look for instead:

• Clear information about the prescribing clinician
• Required video consultations (not just text-based questionnaires)
• Discussion of risks, side effects, and alternatives
• Structured follow-up appointments
• Transparent pricing (both for the consultation and medication)
• Acceptance of insurance when applicable

Klarity Health, for example, offers transparent pricing, works with licensed providers in all 50 states, accepts both insurance and cash pay, and prioritizes comprehensive patient evaluation and ongoing support—not just quick prescriptions.

Cost Considerations: Insurance vs. Cash Pay

One of the biggest questions patients have is about affordability.

Insurance Coverage

Coverage for GLP-1 weight loss medications varies significantly:

• Medicare Part D generally does not cover weight loss drugs (though there’s ongoing legislative pressure to change this)
• Private insurance may cover Wegovy if you meet medical necessity criteria, but many plans exclude weight loss medications or require high copays
• Prior authorization is often required, which can delay access

If your insurance covers the medication, you may pay anywhere from $25 to $500+ per month depending on your plan.

Cash/Self-Pay Options

Without insurance, these medications are expensive:

• Wegovy: $1,300–$1,500/month retail
• Ozempic: $900–$1,000/month retail
• Mounjaro/Zepbound: $1,000–$1,200/month retail

However, several options can reduce costs:

• Manufacturer savings cards can lower out-of-pocket costs significantly (though they typically exclude Medicare patients)
• Telehealth platforms may negotiate pharmacy discounts
• Compound alternatives: As of 2025, FDA-approved compounding is very limited, but some telehealth providers are exploring alternative incretin mimetics (always verify FDA compliance)

Transparency is key. Klarity Health provides clear pricing information upfront, helps patients understand insurance coverage, and offers affordable cash-pay options when insurance isn’t available.

Safety and Clinical Best Practices

While telehealth makes access easier, safety standards remain paramount. Here’s what responsible telehealth prescribing looks like:

Initial Evaluation

• Comprehensive medical history
• Review of current medications (checking for interactions)
• Assessment of contraindications
• Calculation and verification of BMI
• Discussion of previous weight loss attempts

Informed Consent

Patients should be educated about:

• How the medication works
• Common side effects (nausea, vomiting, diarrhea, constipation)
• Serious but rare risks (pancreatitis, gallstones, thyroid tumors)
• The importance of lifestyle changes alongside medication
• What to do if side effects occur

Monitoring and Follow-Up

• Regular weight checks
• Symptom assessment
• Dose adjustments as needed
• Periodic lab work (typically every 3–6 months)
• Evaluation of treatment effectiveness (if you haven’t lost at least 5% of body weight after 3–4 months at the maintenance dose, the medication may not be working well for you)

Lifestyle Integration

Medication alone isn’t a magic solution. Effective programs include:

• Nutritional counseling
• Physical activity recommendations
• Behavioral health support when needed
• Strategies for long-term weight maintenance

Some states (like Connecticut and Virginia) legally require that weight loss prescriptions be accompanied by diet and exercise counseling.

What About Compounded Semaglutide?

You may have heard about cheaper ‘compounded’ versions of these medications. Here’s what you need to know:

During the COVID-19 pandemic and subsequent drug shortages, the FDA allowed compounding pharmacies to make custom versions of semaglutide. However, in May 2025, the FDA declared the shortage over and effectively banned routine compounding of semaglutide for weight loss.

Why the ban?

• Quality and consistency concerns
• Reports of adverse events
• Availability of FDA-approved alternatives

As of December 2025, you should only receive FDA-approved, brand-name GLP-1 medications from licensed pharmacies. Some telehealth companies that previously offered compounded versions (like Hims & Hers) had to discontinue those programs.

If a provider offers suspiciously cheap ‘semaglutide,’ verify it’s FDA-approved. Compounded versions are now limited to very specific circumstances (like documented allergies to inactive ingredients) and require clear FDA compliance.

Looking Ahead: The Future of Telehealth Weight Loss Treatment

The regulatory landscape continues to evolve, generally in the direction of greater access with appropriate safeguards.

Federal Developments

• The DEA’s temporary telehealth flexibilities for controlled substances are expected to be extended beyond 2025, possibly becoming permanent
• The TREATS Act (reintroduced in October 2025) would permanently allow some controlled substance prescribing via telehealth, particularly for addiction treatment
• Congressional support for telehealth remains strong across party lines

State Trends

• More states are granting full practice authority to nurse practitioners (34 states plus DC as of 2025, up from 23 in 2018)
• Interstate licensure compacts are expanding, making it easier for providers to treat patients across state lines
• States are generally modernizing telehealth laws rather than restricting them

Clinical Innovation

• New GLP-1 and dual-incretin medications are in development
• Oral versions may become available (currently all are injectable)
• Research continues on optimal dosing, combination therapies, and long-term outcomes

For patients, this means telehealth access to weight loss medications will likely remain available and may even become more streamlined over time.

State-by-State Quick Reference

Here’s a quick summary of rules in key states (always verify current requirements with your provider):

No in-person requirement: California, Connecticut, Illinois, New York, Pennsylvania, Washington

Initial in-person exam required: Arkansas, Delaware, Georgia, Mississippi, New Jersey, North Dakota, South Carolina, Texas, Utah, Virginia

Regular follow-ups mandated: Florida (every 3 months), Virginia (within 30 days of starting)

Additional documentation required: Connecticut (behavioral counseling plan), New Jersey (comprehensive baseline evaluation including labs and psych screening), Virginia (lab work and personalized diet/exercise plan)

NP independent practice: California, New York, Washington, Arizona, Oregon, Utah, Connecticut, Maryland, Rhode Island, Vermont, New Mexico, Nevada, Idaho, Montana, Wyoming, Nebraska, Iowa, Minnesota, Wisconsin, Maine, New Hampshire, Alaska, Hawaii, North Dakota (and others)

NP requires collaboration: Texas, Florida, Pennsylvania, Georgia, South Carolina, Mississippi, Arkansas, Alabama, Louisiana, Tennessee, Kentucky, North Carolina, Virginia, West Virginia, Indiana, Ohio, Michigan, Kansas, Oklahoma, Missouri (and others)

Frequently Asked Questions

Can I use telehealth for weight loss medications if I live in a rural area?

Absolutely. Telehealth is especially beneficial for patients in rural or underserved areas where access to weight management specialists may be limited. As long as your provider is licensed in your state and you have a reliable internet connection for video visits, location isn’t a barrier.

Do I need to use my insurance, or can I pay cash?

You have options. If your insurance covers the medication and telehealth visits, using it may reduce your costs. However, many patients choose to pay cash for telehealth consultations (often more affordable than traditional office visits) and then use insurance, manufacturer coupons, or pharmacy discount programs for the medication itself. Klarity Health accepts both insurance and cash pay, giving you flexibility.

How long do I need to stay on the medication?

These are typically long-term treatments. Clinical trials show that most patients regain weight after stopping the medication, so many providers recommend staying on a maintenance dose indefinitely (similar to how you’d take medication for high blood pressure or diabetes). Your provider will discuss the right duration for your individual situation.

What happens if I move to a different state?

Your provider must be licensed in the state where you’re physically located. If you move, you’ll need to either find a new provider licensed in your new state, or work with a telehealth service (like Klarity) that has providers licensed in multiple states and can transition your care.

Are there any dietary restrictions while taking these medications?

There are no strict forbidden foods, but because GLP-1s slow stomach emptying, you may naturally gravitate toward smaller meals and find that high-fat or very heavy foods cause discomfort. Your provider should discuss nutrition strategies that work well with the medication—typically emphasizing protein, fiber, and nutrient density.

Can I get these medications if I’ve had bariatric surgery?

Possibly. Some patients use GLP-1 medications after bariatric surgery if they experience weight regain. However, this requires careful evaluation since your anatomy and nutritional needs may be different. Discuss your surgical history with your provider during your initial consultation.

Take the Next Step with Confidence

If you’re considering weight loss medication through telehealth, you now have the information you need to make an informed decision. Remember:

✅ Telehealth prescribing of GLP-1 medications like Wegovy is legal under federal law✅ State requirements vary—some need an initial in-person exam, others don’t✅ You must work with a provider licensed in your state✅ Legitimate services require thorough evaluation and ongoing monitoring✅ These medications work best as part of a comprehensive weight management plan

At Klarity Health, we make accessing evidence-based weight loss treatment straightforward and safe. Our licensed providers are available across all 50 states, we accept both insurance and cash pay, and we offer transparent pricing with no hidden fees. Most importantly, we prioritize your long-term health—not just quick prescriptions.

Ready to explore whether GLP-1 medications are right for you? Schedule a consultation with Klarity Health to speak with a licensed provider who can evaluate your individual situation, answer your questions, and create a personalized treatment plan that fits your life and your state’s requirements.

Your weight loss journey deserves expert guidance and convenient access—and with today’s telehealth options, both are within reach.

Citations and Sources

This article is based on current federal and state regulations verified as of December 17, 2025. Key sources include:

1. DEA and HHS Announcement – ‘DEA and HHS Extend Telemedicine Flexibilities through 2025’ (www.dea.gov, November 15, 2024) – Official federal announcement extending COVID-era telehealth rules for controlled substances through December 31, 2025.

2. Axios – ‘DEA extends COVID-era telehealth prescribing rules through 2025’ (www.axios.com, November 18, 2024) – News coverage confirming the third extension of federal telehealth flexibilities.

3. McDermott Will & Emery Legal Analysis – ‘DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025’ (www.mwe.com, November 18, 2024) – Expert legal analysis of current DEA regulations and their implications for telehealth prescribing.

4. Goodwin Procter Law Firm – ‘Changing Regulatory and Reimbursement Landscape for Weight Loss Drugs’ (www.goodwinlaw.com, March 27, 2024) – Comprehensive review of state-specific regulations for obesity medications in Florida, New Jersey, Virginia, and other states.

5. Reuters – ‘Telehealth company Hims to cut 4% of workforce amid ban on weight-loss drug copies’ (www.reuters.com, May 30, 2025) – Coverage of FDA enforcement action ending compounded semaglutide availability.

For a complete list of sources including state medical board regulations, statutory references, and additional federal guidance documents, please see the full research documentation. All regulatory information has been verified as current as of December 17, 2025.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a licensed healthcare provider about your individual health needs and treatment options. Regulations and medical guidelines are subject to change; verify current requirements with your provider.

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid